Literature DB >> 16105800

Brainstem axonal degeneration in mice with deletion of selenoprotein p.

William M Valentine1, Kristina E Hill, Lori M Austin, Holly L Valentine, Daniel Goldowitz, Raymond F Burk.   

Abstract

Selenoprotein P is an abundant extracellular protein that is expressed in liver, brain, and other tissues. Studies in mice with the selenoprotein P gene deleted (Sepp-/- mice) have implicated the protein in maintaining brain selenium. Sepp-/- mice fed a normal or low selenium diet develop severe motor impairment and die, but Sepp-/- mice fed a high selenium diet remain clinically unimpaired. As an initial step to evaluate the effect of selenoprotein P deletion on central nervous system architecture, the brains and cervical spinal cords of Sepp-/- and Sepp+/+ mice fed low or high selenium diets were examined by light and electron microscopy. Brains of Sepp-/- mice demonstrated no gross abnormalities. At the light microscopic level, however, Sepp-/- mice fed either the selenium deficient diet or the high selenium diet had enlarged dystrophic axons and degenerated axons in their brainstems and cervical spinal cords. No axonal lesions were observed in the Sepp+/+ mice fed either diet. Electron microscopy demonstrated that the enlarged axons in the Sepp-/- mice were packed with organelles, suggesting a deficit in fast axonal transport. The similar severity of axonal lesions observed in Sepp-/- mice fed the 2 diets suggests that axonal dystrophy is a common phenotype for deletion of selenoprotein P regardless of selenium intake and that additional studies will be required to determine the pathogenesis of the neurological signs and mortality observed in Sepp-/- mice fed a low selenium diet.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105800     DOI: 10.1080/01926230500243045

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  12 in total

1.  Progression of neurodegeneration and morphologic changes in the brains of juvenile mice with selenoprotein P deleted.

Authors:  Samuel W Caito; Dejan Milatovic; Kristina E Hill; Michael Aschner; Raymond F Burk; William M Valentine
Journal:  Brain Res       Date:  2011-05-05       Impact factor: 3.252

2.  Neuronal and ependymal expression of selenoprotein P in the human brain.

Authors:  M Scharpf; U Schweizer; T Arzberger; W Roggendorf; L Schomburg; J Köhrle
Journal:  J Neural Transm (Vienna)       Date:  2007-01-25       Impact factor: 3.575

3.  Absence of selenoprotein P but not selenocysteine lyase results in severe neurological dysfunction.

Authors:  A V Raman; M W Pitts; A Seyedali; A C Hashimoto; L A Seale; F P Bellinger; M J Berry
Journal:  Genes Brain Behav       Date:  2012-05-03       Impact factor: 3.449

4.  Association of selenoprotein p with Alzheimer's pathology in human cortex.

Authors:  Frederick P Bellinger; Qing-Ping He; Miyoko T Bellinger; Yanling Lin; Arjun V Raman; Lon R White; Marla J Berry
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

5.  Role of selenium on calcium signaling and oxidative stress-induced molecular pathways in epilepsy.

Authors:  Mustafa Nazıroglu
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

6.  Overexpression of selenoprotein H reduces Ht22 neuronal cell death after UVB irradiation by preventing superoxide formation.

Authors:  Kamel E Ben Jilani; Jun Panee; Qingping He; Marla J Berry; Ping-An Li
Journal:  Int J Biol Sci       Date:  2007-02-11       Impact factor: 6.580

7.  Altered hippocampus synaptic function in selenoprotein P deficient mice.

Authors:  Melinda M Peters; Kristina E Hill; Raymond F Burk; Edwin J Weeber
Journal:  Mol Neurodegener       Date:  2006-09-19       Impact factor: 14.195

8.  Selenium and selenoprotein deficiencies induce widespread pyogranuloma formation in mice, while high levels of dietary selenium decrease liver tumor size driven by TGFα.

Authors:  Mohamed E Moustafa; Bradley A Carlson; Miriam R Anver; Gerd Bobe; Nianxin Zhong; Jerrold M Ward; Christine M Perella; Victoria J Hoffmann; Keith Rogers; Gerald F Combs; Ulrich Schweizer; Glenn Merlino; Vadim N Gladyshev; Dolph L Hatfield
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

Review 9.  Selenium in the Therapy of Neurological Diseases. Where is it Going?

Authors:  Agnieszka Dominiak; Anna Wilkaniec; Piotr Wroczyński; Agata Adamczyk
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 10.  Selenium, Selenoproteins, and Immunity.

Authors:  Joseph C Avery; Peter R Hoffmann
Journal:  Nutrients       Date:  2018-09-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.